TECLIVO Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for TECLIVO with the United States Patent and Trademark Office. The USPTO has given the TECLIVO trademark a serial number of 88895922. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by Pfizer Inc.. The TECLIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
teclivo

General Information

Serial Number88895922
Word MarkTECLIVO
Filing DateThursday, April 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 4, 2020NEW APPLICATION ENTERED
Wednesday, May 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 23, 2020ASSIGNED TO EXAMINER
Thursday, June 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 31, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, January 13, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 15, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021SOU EXTENSION 1 FILED
Wednesday, July 21, 2021SOU EXTENSION 1 GRANTED
Wednesday, January 12, 2022SOU EXTENSION 2 FILED
Wednesday, January 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 12, 2022SOU EXTENSION 2 GRANTED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU EXTENSION 4 GRANTED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 15, 2022SOU EXTENSION 3 FILED
Monday, August 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU TEAS EXTENSION RECEIVED
Monday, January 9, 2023SOU EXTENSION 4 FILED
Wednesday, January 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 7, 2023SOU EXTENSION 5 FILED
Friday, August 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 11, 2023SOU EXTENSION 5 GRANTED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

teclivo preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone